Dear Pascal Soriot,
I’d like to talk to you about your priorities.
Your company, AstraZeneca, is investing heavily in the development of a Covid-19 vaccine — and you have said you have no intention of turning a profit on any vaccine in the midst of a pandemic.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.